COMBIPRES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Combipres, and what generic alternatives are available?
Combipres is a drug marketed by Boehringer Ingelheim and is included in one NDA.
The generic ingredient in COMBIPRES is chlorthalidone; clonidine hydrochloride. There are twenty-one drug master file entries for this compound. Additional details are available on the chlorthalidone; clonidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COMBIPRES?
- What are the global sales for COMBIPRES?
- What is Average Wholesale Price for COMBIPRES?
Summary for COMBIPRES
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Formulation / Manufacturing: | see details |
DailyMed Link: | COMBIPRES at DailyMed |
![COMBIPRES drug patent expirations Drug patent expirations by year for COMBIPRES](/p/graph/s/t/COMBIPRES-patent-expirations.png)
US Patents and Regulatory Information for COMBIPRES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Boehringer Ingelheim | COMBIPRES | chlorthalidone; clonidine hydrochloride | TABLET;ORAL | 017503-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Boehringer Ingelheim | COMBIPRES | chlorthalidone; clonidine hydrochloride | TABLET;ORAL | 017503-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Boehringer Ingelheim | COMBIPRES | chlorthalidone; clonidine hydrochloride | TABLET;ORAL | 017503-003 | Apr 10, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for COMBIPRES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | COMBIPRES | chlorthalidone; clonidine hydrochloride | TABLET;ORAL | 017503-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Boehringer Ingelheim | COMBIPRES | chlorthalidone; clonidine hydrochloride | TABLET;ORAL | 017503-003 | Apr 10, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Boehringer Ingelheim | COMBIPRES | chlorthalidone; clonidine hydrochloride | TABLET;ORAL | 017503-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for COMBIPRES
See the table below for patents covering COMBIPRES around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 353721 | ⤷ Sign Up | |
France | 3968 | ⤷ Sign Up | |
Netherlands | 123037 | ⤷ Sign Up | |
Finland | 42564 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |